| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 5e-05 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 9e-05 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |